Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA have?
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA has 455 citations in the OpenAlex counts ScholarIQ stores.
When was Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA published?
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA has 2018 year in the ScholarIQ index.
What is the open-access status of Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA?
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA has closed oa status in the ScholarIQ index.
What is the DOI of Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA?
The DOI for Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA is on the source record.
What is the PMID of Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA?
The PMID for Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA is on the source record.
What is the OpenAlex record for Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA?
The OpenAlex for Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA is on the source record.